BLANENSE
Glaxo Group Limited
Trademark Registered: 2016-08-30
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85775773 |
| Registration Number | 5029437 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Christopher M. Hanes |
| Attorney Docket Number | TMR\5088186\ |
| Law Office Assigned | M10 |
| Employee Name | VOHRA, SANJEEV KUMAR |
Timeline
| 2012-11-09 | Application Filed |
| 2013-05-07 | Published for Opposition |
| 2016-08-30 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-08-30 | Status: Live/Registered |
| 2016-08-30 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Glaxo Group Limited |
| Address | 980 Great West Road Brentford, Middles GB TW89GS |
| Legal Entity Type | Corporation |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2012-11-13 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2012-11-16 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2013-03-07 | 3 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2013-03-11 | 4 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2013-03-11 | 5 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2013-03-11 | 6 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2013-03-11 | 7 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2013-03-11 | 8 CNSA P: |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2013-03-20 | 9 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2013-03-20 | 10 CHAN I:Incoming Correspondence |
| ASSIGNED TO LIE | 2013-03-26 | 11 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2013-03-29 | 12 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2013-04-17 | 13 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2013-05-07 | 14 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2013-05-07 | 15 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2013-07-02 | 16 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2013-12-16 | 17 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2013-12-16 | 18 EXT1 S: |
| EXTENSION 1 GRANTED | 2013-12-16 | 19 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2013-12-18 | 20 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2014-06-23 | 21 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2014-07-15 | 22 AITU A:Allowance for Publication |
| EXTENSION 2 FILED | 2014-06-23 | 23 EXT2 S: |
| EXTENSION 2 GRANTED | 2014-07-16 | 24 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2014-07-17 | 25 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2014-12-02 | 26 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2014-12-02 | 27 EXT3 S: |
| EXTENSION 3 GRANTED | 2014-12-09 | 28 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2014-12-10 | 29 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2015-06-01 | 30 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2015-06-15 | 31 AITU A:Allowance for Publication |
| EXTENSION 4 FILED | 2015-06-01 | 32 EXT4 S: |
| EXTENSION 4 GRANTED | 2015-06-16 | 33 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2015-06-17 | 34 EXRA E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2015-06-22 | 35 TCCA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2015-12-09 | 36 EEXT I:Incoming Correspondence |
| EXTENSION 5 FILED | 2015-12-09 | 37 EXT5 S: |
| EXTENSION 5 GRANTED | 2015-12-21 | 38 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2015-12-22 | 39 EXRA E:E-Mail |
| TEAS DELETE 1(B) BASIS RECEIVED | 2016-05-23 | 40 D1BR I:Incoming Correspondence |
| NOTICE OF ALLOWANCE CANCELLED | 2016-05-23 | 41 IUCN S: |
| 1(B) BASIS DELETED; PROCEED TO REGISTRATION | 2016-07-27 | 42 DP1B I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2016-08-30 | 43 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2021-08-30 | 44 REM1 E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-08-01 | 45 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-08-01 | 46 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2022-08-01 | 47 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-08-01 | 48 TCCA I:Incoming Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2023-03-10 | 49 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BLANENSE 97526371 not registered Live/Pending |
Glaxo Group Limited 2022-07-29 |
 BLANENSE 85775773 5029437 Live/Registered |
Glaxo Group Limited 2012-11-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 